Abiopharma

News list

Marks Gilbert Lynn 🟢 acquired 11.6K shares of AN2 Therapeutics, Inc. (ANTX) Transaction Date: Jan 12, 2026 | Filing ID: 013035

Full text

News bot Jan. 29, 2026, 2:23 p.m.
🔍 Marks Gilbert Lynn (Executive)

Company: AN2 Therapeutics, Inc. (ANTX)

Report Date: 2026-01-12
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 11,560
Detailed Transactions and Holdings:
- Acquired 11,560 shares of Common Stock (Direct)
  Date: 2026-01-12 | Code: A | equity_swap_involved: false | shares_owned_after: 75,309.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.